Asenapine transdermal patch - Lohmann Therapie-Systeme
Alternative Names: Asenapine TTS - Lohmann Therapie-SystemeLatest Information Update: 28 Aug 2024
At a glance
- Originator Lohmann Therapie-Systeme
- Class Antipsychotics; Heterocyclic compounds with 4 or more rings; Oxepins; Pyridines; Pyrrolidines; Small molecules
- Mechanism of Action Alpha adrenergic receptor antagonists; Dopamine receptor antagonists; Histamine H1 receptor antagonists; Serotonin receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Schizophrenia
Most Recent Events
- 28 Aug 2024 No recent reports of development identified for research development in Schizophrenia in Germany (Transdermal)
- 06 Jul 2020 Lohmann Therapie-Systeme and LIVZON enters into license and collaboration agreement to develop and commercialise asenapine transdermal patch in China, including Hong Kong and Macau
- 06 Jul 2020 Early research in Schizophrenia in Germany (Transdermal)